Abstract:Highlights • We propose a novel drug repurposing approach, which integrates gene expression profile and gene regulatory network to compute inhibition score using the shortest distance in the tissue-specific network, called DRIE. • Experimental results on multiple datasets indicate that DRIE outperforms state-of-the-art methods for cancer drug repurposing prediction. • Case studies show that our method can effectively discover novel drug-disease associations. Numerous computational drug repurposing methods have emerged as efficient alternatives to costly and time-consuming traditional drug discovery approaches. Some of these methods are based on the assumption that the candidate drug should have a reversal effect on disease-associated genes. However, such methods are not applicable in the case that there is limited overlap between disease-related genes and drug-perturbed genes. In this study, we proposed a novel D rug R epurposing method based on the I nhibition E ffect on gene regulatory network ( DRIE ) to identify potential drugs for cancer treatment. DRIE integrated gene expression profile and gene regulatory network to calculate inhibition score by using the shortest path in the disease-specific network. The results on eleven datasets indicated the superior performance of DRIE when compared to other state-of-the-art methods. Case studies showed that our method effectively discovered novel drug-disease associations. Our findings demonstrated that the top-ranked drug candidates had been already validated by CTD database. Additionally, it clearly identified potential agents for three cancers (colorectal, breast, and lung cancer), which was beneficial when annotating drug-disease relationships in the CTD. This study proposed a novel framework for drug repurposing, which would be helpful for drug discovery and development. Availability and implementation The source code of our method is freely available at https://github.com/eshinesimida/DRIE. Graphical abstract Download : Download high-res image (178KB) Download : Download full-size image

Drug Repurposing by Integrated Literature Mining and Drug-Gene-Disease Triangulation

DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features

Computational drug repositioning: from data to therapeutics.

Computational Drug Repositioning for Cancer Therapeutics

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

Application of artificial intelligence and machine learning in drug repurposing

A Review of Drug Repositioning Based Chemical-induced Cell Line Expression Data

Knowledge-driven drug repurposing using a comprehensive drug knowledge graph

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

Drug repositioning based on the heterogeneous information fusion graph convolutional network

DrugReAlign: a multisource prompt framework for drug repurposing based on large language models

The landscape of the methodology in drug repurposing using human genomic data: a systematic review

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds

Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines

A drug repurposing method based on inhibition effect on gene regulatory network

Drug Repurposing for Cancer Treatment Through Global Propagation with a Greedy Algorithm in a Multilayer Network

An Analytical Review of Computational Drug Repurposing

Integrated edge information and pathway topology for drug-disease associations

Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension

Accelerating Complex Disease Treatment through Network Medicine and GenAI: A Case Study on Drug Repurposing for Breast Cancer

Drug Repurposing using Consilience of Knowledge Graph Completion Methods